Feb 1, 2023 8:05am EST Ensysce Biosciences Announces the Distribution of Series A Preferred Stock to Holders of Its Common Stock
December 15, 2022 As We Enter “the Most Dangerous Time of the Year”, a Solution to Prescription Opioid Overdose may be in Sight
November 9, 2022 Dr. Vince Clinical Research Announces Dosing of Ensysce's PF614 Compound in Human Abuse Potential Trial